uremia, experiments were designed to assess the effect of renal failure serum upon the reactivity of normal human lymphocytes to phytohemagglutinin in vitro. Normal buffy coat cells were resuspended in sera obtained from normal subjects and from 14 patients with renal failure, then stimulated with phytohemagglutinin M and the cellular response measured by the increase in thymidine or uridine uptake. The mean thymidine uptake by stimulated cells in normal sera was 14,389 ± 1695 (SEM) cpm per 2 X 106 lymphocytes. Uridine uptake under the same conditions was 12,540 ±1887 cpm. Compared to these are a mean thymidine uptake of 2740 ±457 cpm and uridine uptake of 3928 ±667 cpm in renal failure sera. Both differences are significant at P < 0.01 level.
stimulated cells in normal sera was 14,389 ± 1695 (SEM) cpm per 2 X 106 lymphocytes. Uridine uptake under the same conditions was 12,540 ±1887 cpm. Compared to these are a mean thymidine uptake of 2740 ±457 cpm and uridine uptake of 3928 ±667 cpm in renal failure sera. Both differences are significant at P < 0.01 level.
For controls representing "chronic illnesses," sera from patients with pneumococcal meningitis, cirrhosis of the liver without jaundice, rheumatoid arthritis, and paraplegia with urinary tract infection did not cause suppression. No single drug had been taken by all the renal failure patients; three patients were taking no drugs.
The serum from one patient with acute renal failure suppressed thymidine uptake while her serum obtained after recovery from her illness supported a normal lymphocyte response. Improvement of lymphocyte response was also noted in 9 of 10 sera obtained from patients immediately after hemodialysis. These observations plus the inhibition of stimulated cells by normal serum mixed with renal failure serum indicate the presence of a dialyzable inhibitory factor rather than the absence of a supporting factor in the renal failure sera.
Lymphocytes preincubated for 24 hr in renal failure serum responded normally when transferred to normal serum and stimulated. Cells stimulated in normal serum and transferred to renal failure serum within the initial Received for publication 14 December 1970 and in revised form 29 January 1971 . 24 hr of incubation demonstrated depressed thymidine uptake. Also, cell survival for 72 hr incubation as judged by trypan blue exclusion and chromium-51 release was similar in normal and renal failure sera. Thus, the suppressive effect of renal failure serum does not depend upon the initial phytohemagglutinin-cell interaction nor upon a significant cytotoxic effect.
These studies demonstrate that a dialyzable factor (s) in the serum of patients with renal failure can greatly suppress one parameter by which an immune function of circulating lymphocytes is assessed and provides at least, a partial explanation for delayed homograft rejections in renal failure as well as the susceptibility of such patients to various infections.
INTRODUCTION
Infections represent a major problem in patients with renal failure and uremia (1) (2) (3) . In attempting to define factors which may provide the basis for this clinical observation, there appear to be multiple potential determinants. Among these could be included increased exposure to the potential hazard of exogenous microbial agents in the hospital environment as well as defective host defense mechanisms. The latter would include those immune mechanisms mediated through B-cell lines by the production of specific immunoglobulins and those mediated through T (thymic dependent) lymphocytes and defined as cellular immunity. Cellular immunity may be assessed by measuring a series of responses involving the small lymphocyte and mediators released from such lymphocytes in response to specific activation. Because cell-mediated reactions play a major role in the recovery from various infections characterized by intracellular parasitism such as tuberculosis, "coliform" bacillary in (12) . In brief, the heparinized whole blood was centrifuged at 1500 rpm for 5 min in a benchtop centrifuge. The England Nuclear Corp., Boston, Mass.) was added to each tube. After the additional hour of incubation, the tubes were placed in an ice bath. They were then centrifuged at 50C. The cells were washed twice with cold PBS, lysed, and then precipitated with 3 ml of cold 5% trichloroacetic acid (TCA). The precipitate was washed once with cold 5%o TCA and once with cold absolute methanol, which was then decanted. The tubes were inverted and allowed to air dry. Then 0.5 ml of 2 N NaOH was added to digest the precipitate. 0.1 ml of the digested material was transferred to a scintillation vial (Beckman, Fullerton, Calif.) to which was added 0.4 ml of fresh 2 N NaOH and the volume of acidic solubilizer (BBS-2, Beckman) needed to achieve a neutral pH (usually 1.3 ml). The contents were thoroughly mixed on a vortex mixer. 10 ml of scintillation fluid (2,5- RNA synthesis. The effect of renal failure upon the RNA response of stimulated normal lymphocytes was also determined. For these experiments, the cells were prepared as previously described except that the incubation period was limited to 24 hr. During the last 1 hr of culture, 5 ,ACi of uridine-5-3H (SA 26.2 Ci per mm, New England Nuclear) was added to each tube. At 24 hr the cells were treated as previously described for thymidine uptake.
Cell viability. Cell viability was determined by cell counts with trypan blue of unstimulated cultures in both normal and renal failure serum. Cells were prepared and incubated as described for DNA synthesis. After 72 hr of incubation the tubes were centrifuged, the culture media decanted, and the cells suspended in 2 ml normal saline. Total cell counts were performed. In addition, three drops of the cell suspension were mixed with one drop of 1% trypan blue. The number of stained cells among 200 cells was counted after waiting 15 min (13) .
Cytotoxicity of the culture conditions was further tested by a method adapted from Rogentine and Plocinik (14) . 2 g of washed spun glass (Owens-Corning Fiberglass Corp., Toledo, Ohio) was packed tightly into a 10 ml glass syringe barrel and autoclaved. A three-way stopcock was attached to the syringe. This column was placed in a 370C incubator and void volume portions of leucocyte-rich plasma were placed on the column for 15-min periods with each portion being displaced by another. The last portion was displaced from the column with PBS but the column was not washed further. The cells were sedimented by centrifugation and the contaminating erythrocytes were lysed by first suspending the cell button in 2 ml of cold PBS and then rapidly adding 5 ml cold distilled water. The suspension was agitated for 30 sec and isotonicity was restored with 1.5 ml of cold 5 times concentrated PBS. The suspension was centrifuged and the sedimented cells diluted with 5 ml Eagle's MEM containing 15%o normal serum by volume for total and differential cell count. This technique yielded populations which were 95-97%o lymphocytes. Sodium chromate-5'Cr (SA 65 mCi/mg, New England Nuclear) 40 /Ci per 50 X 106 lymphocytes was added and the suspension incubated in a 370C water bath with constant gentle agitation for 30 min. The cells were washed three times with cold PBS and distributed into culture tubes as previously described for DNA synthesis. After 72 hr incubation, the tubes were centrifuged and the supernatant carefully removed from each tube, placed into counting tubes, and counted for 10-min periods in an automatic gamma radiation counter (Packard Instruments, Downers Grove, Ill.). In each experiment, tubes containing 2 X 106 lymphocytes were frozen and thawed rapidly four times and centrifuged for 10 min at 1500 g. This freeze-thaw supernatant radioactivity was arbitrarily set equal to 100%o release. The amount of 5'Cr released in the reaction tubes was expressed as a per cent of the 100%o release counts. RESULTS Sera from 13 patients with chronic renal failure and 1 patient with acute renal failure have been studied (Table I). Of those patients with chronic renal failure, nine had glomerulonephritis, two had malignant hypertension, one had both diabetes mellitus and congestive heart failure, and the etiology of renal failure in one case was unknown. The patient with acute renal failure had postabortal clostridial sepsis associated with intravascular hemolysis from which she completely recovered. At the time serum was obtained all of the patients except one had severe renal failure with serum creatinine concentrations of 13.6 mg/100 ml or greater. Detailed drug histories revealed no single drug which all of the patients had in common and three patients were taking no drugs when the serum samples were obtained.
The thymidine incorporation of normal lymphocytes stimulated with phytohemagglutinin M in normal sera and in the renal failure sera is summarized in Fig. 1 . The mean thymidine incorporation by lymphocytes incubated in normal sera was 14,389 ±1695 (SEM) cpm, while that of lymphocytes incubated in renal failure sera was 2740 ±457 cpm (P < 0.001). There is no overlap between any result in normal serum with that obtained in renal failure serum. There was a trend for greater suppression with higher creatinine and urea centration (1:1200), varying the concentration of PHA between these extremes did not significantly change the difference in response between normal and renal failure sera. Since the variation was least at a PHA dilution of 1: 60; this ratio was employed throughout these studies.
The effect of sera from five patients with renal failure upon RNA synthesis by lymphocytes stimulated with PHA-M was evaluated and is also shown in Table I . In each instance the response in renal failure serum was less than in normal serum. The mean uridine-5-8H incorporation in normal serum for unstimulated cells was 1176 ±157 (SEM) cpm and for stimulated lymphocytes, 12 ,540 +1887 cpm. Unstimulated cells in renal failure sera yielded a mean of 628 ±67 cpm and stimulated cells responded with 3928 ±667 cpm (P < 0.01).
The serum obtained from one patient during acute renal failure was maintained along with a normal serum sample at -70'C until a sample was obtained after the patient's recovery and then the three sera were evaluated in simultaneous parallel cultures. These results are shown in Fig. 2 . The prominent depression of DNA synthesis in acute illness phase serum was not seen in serum obtained after recovery 1 month later.
To evaluate the possibility that factors other than renal failure might have been responsible for the observed depression of thymidine uptake, normal cells were stimulated in medium containing serum from patients with various other types of illnesses; these included patients with pneumococcal meningitis, cirrhosis of the liver without jaundice, rheumatoid arthritis, and paraplegia with urinary tract infection. The patients were taking penicillin, thiazide diuretics, aspirin, and gentamicin when serum samples were obtained. The patient with pneumococcal meningitis was severely ill, with respiration sustained by a ventilator. In each instance, the response obtained was within the normal range (Table  II) .
To determine if the observed suppression of DNA synthesis by stimulated lymphocytes in renal failure serum was due to the presence of an inhibiting factor(s) or the absence of a supporting factor(s), cells were incubated in simultaneous cultures comparing the effects of diluting renal failure serum by normal serum with the effect of decreasing the amount of normal serum alone in the culture tubes. These results are summarized in Fig. 3 . The incorporation of radiolabeled thymidine was less in cell cultures containing 20% serum, consisting of 0.2 ml normal serum and 0.2 ml renal failure serum, than in cell cultures containing 0.2 ml normal serum only (10%).
10 of the 13 patients studied were on a chronic hemodialysis program. Uremic 24 12,162 serum did not inhibit the ability of lymphocytes to respond in a manner similar to cells preincubated in normal serum. Preincubation and stimulation in renal failure serum resulted in the lowest counts. After 72 hr preincubation in renal failure serum followed by stimulation in normal serum, the response was depressed below the response seen with 72 hr preincubation in normal serum. As previously noted, the thymidine incorporation became greater for all cells with longer periods of preincubation in either type of serum (15) . Table IV shows the result of an experiment which is typical of several demonstrating that renal failure serum is capable of inhibiting the incorporation of tritiated thymidine by lymphocytes already in the active state of transformation. Cell cultures were initiated in medium containing normal serum and PHA-M. Medium changes were performed at 1, 6, 24, and 48 hr to fresh medium containing normal or renal failure serum but no PHA-M and the incubation continued for the remainder of 72 hr. Cells which were undisturbed for 72 hr in medium with normal serum incorporated 10,247 cpm. Medium changes at 1, 6, 24, and 48 hr to fresh medium with normal serum yielded similar counts. Cells undisturbed for 72 hr in medium with renal failure serum incorporated 5718 cpm. Change from medium containing normal serum to medium containing renal failure serum at 1, 6, and 24 hr also demonstrated depressed incorporation of counts. The medium change at 48 hr with renal failure serum present only during the last 24 hr of culture incorporated 12,162 cpm.
Cultures were pulse-labeled for 1, 3, and 6 hr to study both the possible interference in uptake of thymidine label by the renal failure serum and the effect of asynchrony in cell cultures. Despite longer labeling periods, marked suppression of thymidine uptake by normal cells in renal failure serum was still evident (Table V) . Thymidine uptake by cells in renal failure serum was a linear function of the labeling period. (4, (16) (17) (18) . In the present studies, controls to assess cell viability in normal as compared with uremic sera utilizing two techniques, trypan blue exclusion and "Cr release, both failed to show any differences in loss of viability by lymphocytes when incubated in uremic and normal serum. In addition, the observation that 24 hr preincubation in renal failure serum with subsequent change to normal serum for 72 hr did not result in suppression of DNA synthesis is evidence against cytotoxicity in that the cell numbers were not readjusted between tubes containing uremic and normal serum at time of transfer. Likewise, the experiments in which it was demonstrated that after 48 hr of stimulation in normal serum, replacement with renal failure serum failed to inhibit DNA synthesis weighs against a cytotoxic factor in renal failure sera. Further, 24 hr would appear to be sufficient time to demonstrate any significant cytotoxic effect, as RNA synthesis of stimulated cells was suppressed by renal failure serum after only 24 hr incubation. Thus, the differences in DNA and RNA synthesis observed between renal failure and normal sera cannot be attributed to differences in cell numbers secondary to cytotoxicity during culture.
The second mechanism which should be considered is the possibility that renal failure serum inactivates or in some way binds phytohemagglutinin M rendering it unable to bind to the lymphocyte. This possibility was excluded by the experiments in which the stimulation was initiated with cells in normal serum which were transferred after 24 hr into renal failure serum, then the incubation continued an additional 48 hr with resultant suppression of thymidine uptake. Similar transfer from normal serum to normal serum resulted in no suppression.
Furthermore, the effect of renal failure serum cannot be explained by interference with the uptake of the radioactive label. Experiments yielded normal responses when cells were stimulated and incubated in normal serum for 48 hr followed by transfer to medium containing renal failure serum for the final 24 hr of incubation. The final 24 hr of incubation includes the labeling period.
Another possible mechanism is that of a toxic action on the part of one or more drugs on lymphocyte function. Detailed review of drug histories revealed no drugs in common to all patients; three patients were taking no drugs. Hence this cannot be invoked as an explanation.
Since neither loss of cell viability, failure of the phytohemagglutinin, nor drug toxicity can be evoked to account for the observed suppression, renal failure serum itself would seem to be responsible. Renal failure serum might be deficient in some factor necessary for lymphocyte function or, as an alternative, might contain an inhibitory substance or substances. The dilution studies, in which it was demonstrated that DNA synthesis was less in a mixture of 0.1 ml of uremic serum plus 0.3 ml of normal serum than even in 0.2 ml of normal serum, would seem to effectively exclude a "deficiency" as the causative mechanism.
Thus, we feel that these studies support the hypothesis that a factor or factors retained by poorly functioning kidneys are responsible for the altered cellular responsiveness to phytohemagglutinin. The factor does not appear to be related to the type of renal disease since the patients had a variety of types varying from chronic glomerulonephritis to acute tubular necrosis secondary to septic abortion. The correlation of the degree of lymphocyte suppression with serum levels of creatinine and urea nitrogen suggest that the magnitude as well as the duration of renal failure is important in determining the level of the suppressive factor. The improvement in cellular response in posthemodialysis sera and serum obtained promptly after recovery from acute renal failure suggests that the factor(s) are dialyzable.
The nature of such a factor has not been defined; it would not appear, however, to be urea or creatinine per se. The observation that small mononuclear cells within the renal medulla are capable of normal immunoglobulin synthesis would provide data which mitigate against a primary role of urea or creatinine (19) . Other investigators have demonstrated that metabolic degradation products, methylguanidine and guanidinosuccinic acid, are retained by poorly functioning kidneys (20) (21) (22) (23) 
